Birth outcomes with antiretroviral exposure
26 August 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Pregnancy
FDA finally approves 4th generation HIV Ag/Ab test in the US
26 August 2010. Related: Antiretrovirals, Treatment access, Pregnancy, Paediatric care, Diagnostics.
Potential impact of new WHO pregnancy guidance (2010)
26 August 2010. Related: Pregnancy, Guidelines.
Access to formula milk for HIV-positive mothers in the UK
26 August 2010. Related: Pregnancy, BHIVA news.
HAART use among women in UK receiving treatment prior to conception
1 June 2010. Related: Conference reports, Pregnancy.
Duration of ruptured membranes and vertical transmission in the UK
1 June 2010. Related: Conference reports, Pregnancy.
Significant rates of unplanned pregnancies among young women born with HIV
1 June 2010. Related: Conference reports, Pregnancy, Paediatric care.
Pregnancy outcomes with efavirenz
1 June 2010. Related: Pregnancy.
OCTANE 2: nevirapine and lopinavir/r are similar when used with tenofovir and FTC in treatment-naive women
2 April 2010. Related: Conference reports, Pregnancy.
HIV incidence and retesting in pregnancy
2 April 2010. Related: Conference reports, Pregnancy.
Efavirenz use in pregnancy and birth outcomes
2 April 2010. Related: Conference reports, Pregnancy.
Pregnancy outcomes in women using non-AZT HAART in Europe
2 April 2010. Related: Conference reports, Pregnancy.
When should HAART be initiated in pregnancy to achieve an undetectable viral load?
2 April 2010. Related: Conference reports, Pregnancy.
Pregnancy outcomes in infants exposed to maternal antiretrovirals in utero
2 April 2010. Related: Conference reports, Pregnancy, Paediatric care.
Maternal TB, HIV and pregnancy
2 April 2010. Related: Conference reports, Women's health, Pregnancy, TB coinfection.
Infant feeding in the UK (2010): draft guidelines online for comment
2 April 2010. Related: Pregnancy, Paediatric care, Guidelines.
TMC278 did not show teratogenic potential in animal models
21 February 2010. Related: Conference reports, Pregnancy.
Etravirine pregnancy data from five cases: no dose adjustment required
21 February 2010. Related: Conference reports, Pregnancy.
Pregnancy not nevirapine associated with risk of hepatotoxicity in large cohort comparison
14 February 2010. Related: Pregnancy.
Birth defects following efavirenz exposure in a South African Hospital
14 February 2010. Related: Pregnancy.
Pharmacokinetics of atazanavir/ritonavir during pregnancy
5 October 2009. Related: Conference reports, Pregnancy.
Presentation with late stage HIV in women diagnosed during pregnancy
5 October 2009. Related: Conference reports, Pregnancy.
Low transmission rates and favourable pregnancy outcomes reported in the DREAM study
5 October 2009. Related: Conference reports, Pregnancy.
Pregnancy rates and outcomes among women in the DART trial
5 October 2009. Related: Conference reports, Pregnancy.
Efavirenz conceptions in Soweto
5 October 2009. Related: Conference reports, Pregnancy.
Impact of regimen and duration of therapy on risk of mother-to-child HIV transmission in Johannesburg
5 October 2009. Related: Conference reports, Pregnancy.
A cost-effectiveness analysis of the OCTANE trial
5 October 2009. Related: Conference reports, Pregnancy.
The PEARL study
5 October 2009. Related: Conference reports, Pregnancy.
Reducing HIV transmission during breastfeeding
23 August 2009. Related: Conference reports, Pregnancy.
A CYP2B6 haplotype influences nevirapine plasma concentrations following a single dose to reduce mother to child transmission
23 August 2009. Related: Conference reports, Pregnancy.
Pregnancy, family planning, and HIV acquisition in HPTN 039
3 June 2009. Related: Conference reports, Pregnancy.
Effect of breast feeding vs formula feeding on maternal health
26 April 2009. Related: Conference reports, Pregnancy.
PEPI-Malawi
26 April 2009. Related: Conference reports, Pregnancy.
Premature delivery and mother-to-child HIV transmission: a risk/benefit analysis among women receiving HAART
20 April 2009. Related: Conference reports, Pregnancy.
Risk factors for adverse pregnancy outcomes in Botswana
20 April 2009. Related: Conference reports, Pregnancy.
Higher risk of transmission with delayed control of maternal viral load despite viral loads of <500 copies/mL at delivery
20 April 2009. Related: Conference reports, Pregnancy.
Lopinavir/r containing regimen superior to nevirapine containing regimen in women previously exposed to single dose nevirapine
20 April 2009. Related: Conference reports, Pregnancy.
Covering the nevirapine tail
20 April 2009. Related: Conference reports, Pregnancy.
Effect of single dose nevirapine on subsequent nevirapine-containing HAART: long term outcomes
20 April 2009. Related: Conference reports, Pregnancy.
High rates of HIV acquisition in pregnancy and post partum in Francistown, Botswana
20 April 2009. Related: Conference reports, Pregnancy.
Antiretroviral Pregnancy Registry finds no increase in congenital anomalies with exposure to tenofovir
27 December 2008. Related: Conference reports, Pregnancy.
No association between maternal antiretrovirals in pregnancy and congenital anomalies
27 December 2008. Related: Conference reports, Pregnancy.
Pharmacokinetics of saquinavir/ritonavir in pregnancy
27 December 2008. Related: Conference reports, Pregnancy.
Course of labour in pregnant HIV-positive women with no contraindication for vaginal delivery
27 December 2008. Related: Conference reports, Pregnancy.
Four weeks of antiretroviral prophylaxis is sufficient for HIV-exposed infants
27 December 2008. Related: Conference reports, Pregnancy.
OCTANE Trial DSMB finds ritonavir-boosted lopinavir superior to nevirapine in HIV-positive women previously exposed to single dose nevirapine
26 December 2008. Related: Pregnancy.
Antiretroviral therapy in pregnant women and pregnancy outcomes in Abidjan, Cote D’Ivoire
26 December 2008. Related: Pregnancy.
HAART use in pregnancy and preterm delivery and low birth weight
30 October 2008. Related: Conference reports, Pregnancy.
Reasons for mother to child transmission in England
30 October 2008. Related: Conference reports, Pregnancy.
Tenofovir safe in pregnancy in macaque model
30 October 2008. Related: Pregnancy.
Case study of multi-drug resistant woman receiving newer antiretroviral drugs in pregnancy
30 August 2008. Related: Conference reports, Pregnancy.
Late pregnancy loss in HIV-positive women
30 August 2008. Related: Conference reports, Pregnancy.
Low rates of MTCT in UK and Ireland
29 August 2008. Related: Pregnancy.
Very low rate of MTCT in women on HAART in UK and Ireland who achieve viral suppression
1 April 2008. Related: Conference reports, Pregnancy.
Predictors of mother to child transmission among women initiating HAART in pregnancy in a South African cohort
1 April 2008. Related: Conference reports, Pregnancy.
Maternal and infant outcomes from the DREAM programme
1 April 2008. Related: Conference reports, Pregnancy.
Nevirapine-resistant HIV present in the latent reservoir following single-dose nevirapine for MTCT prevention
1 April 2008. Related: Conference reports, Pregnancy.
Tenofovir plus FTC reduce NNRTI resistance following single dose nevirapine
1 April 2008. Related: Conference reports, Pregnancy.
Response to treatment after single dose NVP exposure in women
1 April 2008. Related: Conference reports, Pregnancy.
Response to treatment after single dose NVP exposure in infants
1 April 2008. Related: Conference reports, Pregnancy.
Other studies looking at birth outcomes
1 April 2008. Related: Conference reports, Pregnancy.
Infant prophylaxis for postnatal transmission
1 April 2008. Related: Conference reports, Pregnancy.
Antiretroviral drug concentrations in breast milk and breastfeeding infants
1 April 2008. Related: Conference reports, Pregnancy.
Maternal breastfeeding prophylaxis
1 April 2008. Related: Conference reports, Pregnancy.
Risk factors for breastfeeding transmission
1 April 2008. Related: Conference reports, Pregnancy.